Raymond James Financial Services Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-85,738
| Closed | -$4.43M | – | 3365 |
|
|
2022
Q3 | $4.43M | Sell |
85,738
-173,781
| -67% | -$8.98M | 0.01% | 977 |
|
|
2022
Q2 | $6.43M | Buy |
259,519
+12,347
| +5% | +$306K | 0.01% | 815 |
|
|
2022
Q1 | $6.2M | Sell |
247,172
-11,925
| -5% | -$299K | 0.01% | 898 |
|
|
2021
Q4 | $9.43M | Sell |
259,097
-122,763
| -32% | -$4.47M | 0.02% | 711 |
|
|
2021
Q3 | $6.53M | Buy |
381,860
+65,158
| +21% | +$1.11M | 0.01% | 834 |
|
|
2021
Q2 | $4.24M | Buy |
316,702
+81,903
| +35% | +$1.1M | 0.01% | 1057 |
|
|
2021
Q1 | $12M | Buy |
234,799
+34,694
| +17% | +$1.78M | 0.03% | 552 |
|
|
2020
Q4 | $12.4M | Buy |
200,105
+142,812
| +249% | +$8.84M | 0.03% | 484 |
|
|
2020
Q3 | $3.14M | Sell |
57,293
-5,387
| -9% | -$295K | 0.01% | 963 |
|
|
2020
Q2 | $3.61M | Buy |
62,680
+24,232
| +63% | +$1.39M | 0.01% | 836 |
|
|
2020
Q1 | $1.55M | Buy |
38,448
+31,498
| +453% | +$1.27M | 0.01% | 1010 |
|
|
2019
Q4 | $275K | Buy |
+6,950
| New | +$275K | ﹤0.01% | 2370 |
|